New — Free Peptide Starter Guide (2026): 13 chapters, 34 cited studies

Get it free
ToolsCompareGlutathione vs PT-141 (Bremelanotide)

Glutathione vs PT-141 (Bremelanotide)

Side-by-side comparison of key properties, dosing, and research.

Anti-Aging & LongevityImmune Support
Glutathione
Sexual Health & Libido
PT-141 (Bremelanotide)
Summary
Glutathione is the body's master endogenous antioxidant tripeptide, composed of glutamate, cysteine, and glycine. It neutralizes reactive oxygen species, supports detoxification in the liver, recycles other antioxidants (vitamins C and E), and plays a central role in immune function, DNA repair, and cellular redox balance.
PT-141 (Bremelanotide) is a cyclic peptide melanocortin receptor agonist that enhances sexual desire and arousal through central nervous system mechanisms. It is FDA-approved as Vyleesi for premenopausal women with hypoactive sexual desire disorder (HSDD).
Half-Life
Minutes to hours depending on route; IV half-life approximately 10-30 minutes
2–3 hours
Admin Route
Oral (liposomal preferred), Sublingual, Intravenous, Nebulized/inhaled, Topical
SubQ
Research
Typical Dose
250-1000 mg per day
0.5–1.75 mg
Frequency
Once or twice daily
As needed (not daily)
Key Benefits
  • Primary endogenous antioxidant and free radical scavenger
  • Supports hepatic detoxification of xenobiotics and heavy metals
  • Recycles vitamins C and E to maintain antioxidant network
  • Modulates immune function and T-cell activity
  • Skin brightening via inhibition of tyrosinase (IV/topical routes)
  • Neuroprotective in oxidative stress-related conditions
  • Mitochondrial protection and energy metabolism support
  • Enhances sexual desire and libido in both men and women
  • Improves arousal through central nervous system activation
  • Effective for psychological erectile dysfunction
  • Works for female sexual arousal disorder
  • May improve sexual satisfaction and intensity
  • Fast-acting — effects within 45–60 minutes
  • FDA-approved for HSDD in premenopausal women
Side Effects
  • Oral bioavailability is limited (largely hydrolyzed in gut); liposomal or sublingual forms preferred
  • IV administration: rare allergic reactions, vein irritation
  • High-dose supplementation may cause zinc depletion over time
  • Inhaled glutathione may trigger bronchoconstriction in asthmatics
  • Nausea (most common — 40% of users in clinical trials)
  • Facial flushing and warmth
  • Transient blood pressure changes (typically increase then normalize)
  • Headache
  • +2 more
Stacks With